Ebola and Marburg virus antibody prevalence in selected populations of the Central African Republic

被引:67
作者
Gonzalez, JP [2 ]
Nakoune, E
Slenczka, W
Vidal, P
Morvan, JM
机构
[1] Mahidol Univ Salaya, Nakhon Pathom 73170, Thailand
[2] IRD Orstom, Inst Francais Rech Sci Dev Cooperat, Paris, France
[3] Inst Pasteur, Lab Arbovirus & Virus Fievres Hemorrag, Bangui, Cent Afr Republ
[4] Univ Marburg, Inst Virol, D-3550 Marburg, Germany
[5] Minist Affaires Etrangeres, Paris, France
关键词
Ebola virus; Marburg virus; Central African Republic; serology; ecology;
D O I
10.1016/S1286-4579(00)00287-2
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
With the natural history of the filovirus family seemingly unknown, filovirus ecology in its natural environment remains a rudimentary field of research. In order to investigate the maintenance cycle of filovirus in Central Africa, a study was conducted within the rain forest of the General African Republic. The epidemiological study determines the frequency and distribution of filovirus seroprevalence in a selected human population. Using an ELISA, serum samples from Pygmy and non-Pygmy populations were tested for Ebola-Zaire virus and Marburg (MBG) virus antibody. Filovirus antibody reacting sera were found in all zones investigated, and in all populations studied (Ebola virus IgG 5.3%; Marburg virus IgG 2.4%). Pygmies appeared to have a significantly higher seroprevalence (P < 0.03) against Ebola-Zaire virus (7.02%) than non-Pygmies (4.2%). MBG virus or related unknown filovirus strains also seem to be present in the western part of Central Africa. MBG virus antibodies were present in different Pygmy groups (ranging from 0.7 to 5.6%, mean 2.05%) and in several non-Pygmy populations (ranging from 0.0 to 3.9%, mean 3.4%) without an overall significant difference between the two groups (P = 0.14). The poteneialities of nonpathogenic filovirus strains circulating in the General African Republic are discussed. (C) 2000 Editions scientifiques et medicales Elsevier SAS.
引用
收藏
页码:39 / 44
页数:6
相关论文
共 21 条
[1]  
BAHUCHET S, COPING UNCERTAINTY F, P118
[2]  
BECKER S, 1992, MED MICROBIOL IMMUN, V181, P43, DOI 10.1007/BF00193395
[3]  
BOULVERT Y, 1987, NOTICE EXPLICATIVE C
[4]   Prevalence of IgG antibodies to Ebola virus in individuals during an Ebola outbreak, Democratic Republic of the Congo, 1995 [J].
Busico, KM ;
Marshall, KL ;
Ksiazek, TG ;
Roels, TH ;
Fleerackers, Y ;
Feldmann, H ;
Khan, AS ;
Peters, CJ .
JOURNAL OF INFECTIOUS DISEASES, 1999, 179 :S102-S107
[5]   Ebola hemorrhagic fever outbreaks in Gabon, 1994-1997:: Epidemiologic and health control issues [J].
Georges, AJ ;
Leroy, EM ;
Renaut, AA ;
Benissan, CT ;
Nabias, RJ ;
Ngoc, MT ;
Obiang, PI ;
Lepage, JPM ;
Bertherat, EJ ;
Bénoni, DD ;
Wickings, EJ ;
Amblard, JP ;
Lansoud-Soukate, JM ;
Milleliri, JM ;
Baize, S ;
Georges-Courbot, MC .
JOURNAL OF INFECTIOUS DISEASES, 1999, 179 :S65-S75
[6]  
GONZALEZ J-P, 1983, Cahiers O.R.S.T.O.M. (Office de la Recherche Scientifique et Technique Outre-Mer) Serie Entomologie Medicale et Parasitologie, V21, P119
[7]   ANTIBODY PREVALENCE AGAINST HEMORRHAGIC-FEVER VIRUSES IN RANDOMIZED REPRESENTATIVE CENTRAL AFRICAN POPULATIONS [J].
GONZALEZ, JP ;
JOSSE, R ;
JOHNSON, ED ;
MERLIN, M ;
GEORGES, AJ ;
ABANDJA, J ;
DANYOD, M ;
DELAPORTE, E ;
DUPONT, A ;
GHOGOMU, A ;
KOUKABEMBA, D ;
MADELON, MC ;
SIMA, A ;
MEUNIER, DMY .
RESEARCH IN VIROLOGY, 1989, 140 (04) :319-331
[8]  
HEYMANN DL, 1980, J INFECT DIS, V142, P372, DOI 10.1093/infdis/142.3.372
[9]   HEMORRHAGIC-FEVER VIRUS ACTIVITY IN EQUATORIAL AFRICA - DISTRIBUTION AND PREVALENCE OF FILOVIRUS REACTIVE ANTIBODY IN THE CENTRAL-AFRICAN-REPUBLIC [J].
JOHNSON, ED ;
GONZALEZ, JP ;
GEORGES, A .
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 1993, 87 (05) :530-535
[10]  
JOHNSON ED, 1993, T ROY SOC TROP MED H, V87, P532